By Christine on November 24, 2009
GlaxoSmithKline, a pharmaceutical company that manufactures H1N1 vaccination, has requested that Canadian medical centers not use one batch of the immunizations.
Spokesperson for GlaxoSmithKine state that this batch has caused six serious allergic reactions; this is greater than expected. The recalled batch contained approximately 172,000 doses (a total of 7.5 million doses have been distributed in Canada) and was shipped out last month.
No other countries have been affected by this recall.
Posted in Health
Christine lives in Northern California with her husband and two children...and still pinches herself every day at how lucky she is. In her former life she was in medical school, but a month after graduating she gave birth to her son. After taking six months off (twice) to be home with him before starting her Internship, she left medicine behind and has never looked back (except when contemplating those student loans). Today, when not driving around town shuttling people here and there, she works as a free-lance photographer and interior designer. And writer. And Twitterer. And...
Christine's Website
Loading ...
Comments are closed.